Target intelligence / Profile preview

Broad oral microbial community

Molecular classification
Other
01

Overview

The broad oral microbial community, commonly known as the oral microbiome, is a complex ecological system comprising over 700 species of bacteria, as well as fungi, viruses, and archaea (Dewhirst et al., 2010, Journal of Bacteriology). It plays a vital role in human health by maintaining oral homeostasis, aiding in the initial stages of digestion, and preventing the colonization of pathogenic microorganisms through niche competition (Kilian et al., 2016, British Dental Journal). Dysbiosis within this community—a shift from a symbiotic to a pathogenic state—is the primary cause of prevalent oral diseases such as dental caries and periodontitis (Marsh, 2003, Journal of Clinical Periodontology). Emerging research also links the oral microbiome to systemic conditions, including cardiovascular disease, diabetes, and Alzheimer's disease, often mediated by the systemic spread of oral pathogens or inflammatory mediators (Hajishengallis, 2015, Nature Reviews Immunology). Therapeutic interventions targeting this community include broad-spectrum antimicrobials like chlorhexidine, which disrupt biofilms, and targeted antibiotics like metronidazole, as well as emerging probiotic strategies designed to restore microbial balance (Slots, 2017, Periodontology 2000).

Other names
Oral microbiomeOral microbiotaOral floraOral biofilmDental plaque
02

Mechanism of action

Therapeutic agents interact with the oral microbial community by disrupting cell wall synthesis, inhibiting protein production, or physically removing biofilms to reduce the load of pathogenic species and promote a health-associated microbial balance.

03

Biological functions

Immune system modulationPathogen colonization resistanceMetabolic homeostasisNitrate metabolism
04

Disease associations

Dental cariesPeriodontitisGingivitisCardiovascular diseaseDiabetes mellitusAlzheimer's disease
05

Safety considerations

Microbial dysbiosisAntimicrobial resistanceOral candidiasisSystemic bacteremia
06

Interacting drugs

Chlorhexidine

5 more in the full profile.

07

Biomarkers

16S rRNA gene sequencingShannon diversity indexPorphyromonas gingivalis abundanceStreptococcus mutans levels

Beyond the preview

Go deeper on Broad oral microbial community.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broad oral microbial community.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call